BOCCARELLI, Angelina
 Distribuzione geografica
Continente #
NA - Nord America 5.242
EU - Europa 2.376
AS - Asia 2.310
SA - Sud America 694
Continente sconosciuto - Info sul continente non disponibili 410
AF - Africa 147
OC - Oceania 4
AN - Antartide 1
Totale 11.184
Nazione #
US - Stati Uniti d'America 5.149
SG - Singapore 880
RU - Federazione Russa 877
CN - Cina 628
BR - Brasile 546
IT - Italia 533
SE - Svezia 292
HK - Hong Kong 232
VN - Vietnam 164
DE - Germania 147
UA - Ucraina 117
FI - Finlandia 116
FR - Francia 105
CI - Costa d'Avorio 88
IN - India 75
GB - Regno Unito 72
BD - Bangladesh 69
AR - Argentina 54
ID - Indonesia 49
CA - Canada 40
MX - Messico 29
IQ - Iraq 27
EC - Ecuador 26
JP - Giappone 24
TR - Turchia 21
ZA - Sudafrica 20
CO - Colombia 19
ES - Italia 18
PK - Pakistan 18
BE - Belgio 16
SA - Arabia Saudita 16
PH - Filippine 15
VE - Venezuela 15
IE - Irlanda 14
NL - Olanda 14
PL - Polonia 13
UZ - Uzbekistan 13
JO - Giordania 12
PE - Perù 12
CL - Cile 9
TN - Tunisia 9
KE - Kenya 8
PY - Paraguay 7
AT - Austria 6
CZ - Repubblica Ceca 6
IL - Israele 6
KR - Corea 6
MY - Malesia 6
TH - Thailandia 6
AZ - Azerbaigian 5
BO - Bolivia 5
CR - Costa Rica 5
DZ - Algeria 5
IR - Iran 5
KZ - Kazakistan 5
AL - Albania 4
AU - Australia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
LT - Lituania 4
MA - Marocco 4
NP - Nepal 4
OM - Oman 4
PA - Panama 4
GE - Georgia 3
JM - Giamaica 3
LB - Libano 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
AQ - Antartide 1
BG - Bulgaria 1
BJ - Benin 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
QA - Qatar 1
SC - Seychelles 1
Totale 10.773
Città #
Ashburn 484
Singapore 426
Fairfield 400
Woodbridge 376
Chandler 370
San Jose 342
Jacksonville 262
Nyköping 242
Hong Kong 230
Houston 213
Milan 200
Seattle 193
Cambridge 171
Ann Arbor 164
Wilmington 158
Beijing 150
Council Bluffs 145
Bari 126
Nanjing 101
New York 100
Abidjan 88
Lawrence 88
Roxbury 88
Lauterbourg 82
Ho Chi Minh City 67
Los Angeles 66
Boardman 65
Des Moines 60
Dallas 58
Helsinki 53
Rome 49
São Paulo 43
Princeton 38
Brooklyn 37
Columbus 36
Santa Clara 35
Inglewood 31
Buffalo 30
Hanoi 27
Hebei 26
Dearborn 25
Nanchang 25
Shenyang 25
Tokyo 24
San Diego 23
Munich 21
Jakarta 19
Jiaxing 19
Chicago 18
Pune 18
Belo Horizonte 17
San Francisco 16
Brussels 15
Phoenix 15
The Dalles 15
Tianjin 15
Baghdad 14
Brasília 14
Montreal 14
Moscow 14
Rio de Janeiro 14
Dublin 13
Guangzhou 13
Orem 13
Shanghai 13
Amman 12
Falkenstein 12
Curitiba 11
Tashkent 11
Boston 10
Dhaka 10
Porto Alegre 10
Quito 10
Amsterdam 9
Atlanta 9
Changsha 9
Salvador 9
Turin 9
Denver 8
Figino 8
Johannesburg 8
Lima 8
London 8
Nairobi 8
Nuremberg 8
Paris 8
Riyadh 8
Warsaw 8
Washington 8
Cape Town 7
Chennai 7
Guayaquil 7
Kunming 7
Medellín 7
Ningbo 7
North Bergen 7
Poplar 7
Stockholm 7
Toronto 7
Turku 7
Totale 6.648
Nome #
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 726
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 261
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 254
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 188
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 186
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 185
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 182
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 179
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 173
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 166
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 160
Endothelial cells in the bone marrow of patients with multiple myeloma 139
Antitumour platinum iminoether complexes 135
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 135
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 131
An NMF-Based Methodology for Selecting Biomarkers in the Landscape of Genes of Heterogeneous Cancer-Associated Fibroblast Populations 131
Platinum(II) based anticancer agents with a trans geometry 128
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 126
Antitumour platinum iminoether complexes 126
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 126
Antitumour ruthenium(II)-dimethylsulfoxide complexes 125
Antitumour platinum-iminoether complexes 124
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 122
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 122
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 117
A Critical Appraisal of the Protective Activity of Polyphenolic Antioxidants against Iatrogenic Effects of Anticancer Chemotherapeutics 116
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 115
Antitumor activity of trans platinum complexes 114
Analysis of fibroblast genes selected by NMF to reveal the potential crosstalk between ulcerative colitis and colorectal cancer 112
Chemical and Biological Evaluation of Novel 1H-Chromeno[3,2-c]pyridine Derivatives as MAO Inhibitors Endowed with Potential Anticancer Activity 110
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 109
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 109
A second life for MAO inhibitors? From CNS diseases to anticancer therapy 107
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 104
null 104
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 102
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 101
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 101
A trans-platinum complex showing higher antitumor activity than the cis congeners 100
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 100
Inhibition of matrix metallo proteinases activity by platinum complexes 99
Bone Marrow Fibroblasts and Multiple Myeloma Progression 97
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 97
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 96
Reductive Domino Reaction to Access Chromeno [2, 3-c] isoquinoline-5-amines with Antiproliferative Activities Against Human Tumor Cells 96
Complessi antitumorali di platino a geometria trans 95
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 94
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 94
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 94
null 92
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 92
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 89
Colorectal cancer in Crohn's disease evaluated with genes belonging to fibroblasts of the intestinal mucosa selected by NMF 89
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 88
null 88
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 88
Genomic analysis of the differential processing of antitumor-active and antitumor-inactive trans platinum compuonds 87
Cytotoxicity of some platinum(IV) complexes with ethylenediamine-N,N'-di-3-prppionato ligands 87
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 86
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 84
Screening tests for selecting anticancer metal compounds 83
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 83
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 82
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 81
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 80
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 80
Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF 79
Complessi antitumorali di platino a geometria trans 79
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 78
A new generation of platinum anticancer complexes with trans geometry 77
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 74
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 73
DNA interaction properties of platinum –iminoether complexes 72
Inhibition of matrix metallo proteinase activity by novel platinum complexes with bisphosphonate analogues 71
Platinum(II) complexes with acyclovir: synthesis and biological activity 71
Synthesis and in vitro antitumour activity of platinum acetonimine complexes 70
Nami-A: A ruthenium compound active on solid tumour metasteses by altering the interaction between tumour cells and host 69
Complessi antimetastatici di rutenio 69
null 68
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 68
null 67
null 66
Interazione DNA-isomeri del [PtCl2(DACH)] 66
null 65
null 65
Pharmacological actions of new platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 64
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 63
Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum-Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12 63
Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells 63
The activation of trans geometry in antitumor platinum complexes from iminoether to acetonimine ligands 62
In vitro antitumor activity of 2-acetyl pyridine 4n-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes 60
Rhodium (III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH] [trans-RhCl4(Im)2] (Im = imidazole) 59
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 58
New platinum antitumor complexes with chiral diamines 57
null 55
null 55
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma 55
Synthesis, Biophysical Studies, and Antiproliferative Activity of Platinum(II) Complexes Having 1,2-Bis(aminomethyl)carbobicyclic Ligands 54
null 53
null 52
Totale 10.592
Categoria #
all - tutte 42.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022450 0 0 4 9 25 23 30 19 28 34 102 176
2022/2023995 149 106 78 75 130 118 8 144 147 9 15 16
2023/2024430 30 50 19 18 60 135 4 33 11 10 2 58
2024/20251.540 89 26 129 52 59 113 232 103 52 65 243 377
2025/20264.130 440 148 295 438 421 189 316 86 1.061 305 84 347
2026/2027468 111 203 154 0 0 0 0 0 0 0 0 0
Totale 11.184